How Body Weight Affects Immune Response to COVID-19
Being overweight can impair the body’s antibody response to SARS-CoV-2 infection, but not to the protection offered by vaccination.
Category: Other Infections
Other Infections
Latest
Other Infections
Latest
Nirmatrelvir–Ritonavir Ineffective for Most Post-COVID Conditions
A trial emulation study of veterans with COVID-19 found that the use of the antiviral nirmatrelvir–ritonavir (Paxlovid) was not effective for reducing the risk for many post-COVID-19 conditions.
Other Infections
Latest
American Lung Association Funds $13.6M in Research
The American Lung Association Research Institute awarded $13.6 million in research grants to fund 129 projects to advance science and lessen the burden of lung disease.
FDA Authorizes Updated Novavax COVID-19 Vaccine
The FDA amended the emergency use authorization of the Novavax COVID-19 vaccine, adjuvanted to include the 2023-2024 formula.
Read MoreCOVID-19 Infects Heart Arteries, Increasing Cardiovascular Risks
Though previous studies have shown that SARS-CoV-2 can directly infect tissues such as the lungs and brain, less was known about its effect on the coronary arteries.
Read More
Cell Therapy Slashes COVID-19 Death Risk by 60%
Cell therapy has been shown to significantly reduce the mortality risk in COVID-19 patients based on an analysis of nearly 200 clinical trials conducted since 2020.
Read More
Merck’s COVID Drug May be Causing the Virus to Mutate
Researchers identified unusual COVID-19 mutation patterns that were strongly associated with molnupiravir use and coincided with the drug’s introduction.
Read More
Arthritis Drug Abatacept Tested for Early Immune Modulation in Mild COVID-19
Part of NIH’s STRIVE consortium, the therapeutic may prevent overactive immune systems from causing severe symptoms.
Read More
ACP’s New Guidance Endorses Two COVID-19 Drugs, Advises Against Two
ACP issued four practice points on the pharmacologic and biologic treatment of COVID-19 in the outpatient setting, endorsing two drugs and advising against two others.
Read More
Cough Sounds Could Help Gauge COVID-19 Severity
Cough characteristics in COVID-19 patients could offer a quick and cost-effective method for identifying the severity of the disease in patients.
Read More
Antidepressant Fluvoxamine Offers No Symptom Relief for COVID-19
The ongoing ACTIV-6 study found that fluvoxamine, even at increased dosages, offers no clinical benefit in treating mild-to-moderate COVID-19 symptoms.
Read More
Oral COVID-19 Vaccination Method Shows Promise in Animal Models
A new SARS-CoV-2 vaccination designed to induce the production of Immunoglobulin A orally in monkeys produced the necessary antibodies against the disease without discernable side effects.
Read More
FDA Approves Updated COVID Vaccines from Pfizer and Moderna
The mRNA vaccines are formulated to more closely target currently circulating variants by including a monovalent component that corresponds to the Omicron variant XBB.1.5.
Read More
Pfizer and BioNTech Get Positive EU Opinion for Updated COVID-19 Vaccine
The companies also filed an application with the FDA requesting approval of their Omicron XBB.1.5-adapted monovalent COVID-19 vaccine for individuals 6 months of age and older.
Read More
Investigational DNA-based Vaccine Effective Against COVID-19
In a mouse study, researchers found that the vaccine prompted a robust immune response similar to levels seen with existing mRNA vaccines.
Read More